Results 171 to 180 of about 22,271 (244)

Mitochondrial-Immune Dysfunction in MS: Therapeutic Potential of EV-Mediated Transfer. [PDF]

Cell Mol Neurobiol
Navazi P, Fereidouni M, Erfanian N.
europepmc   +1 more source

Nucleoside-Analog Reverse-Transcriptase Inhibitors (NRTIs) Against Multiple Sclerosis: Comprehensive Review on a Possible Novel Therapeutic Approach. [PDF]

Neurol Int
Martinisi A, Paganetti P.
europepmc   +1 more source

Remyelination therapies are achievable in clinical practice-Yes. [PDF]

Mult Scler
Zuroff L, Cordano C, Green AJ.
europepmc   +1 more source

Secondary demyelination after stroke: Glial cell crosstalk. [PDF]

IBRO Neurosci Rep
Cao R, Liu C, Liu Z, Ou W.
europepmc   +1 more source

Type 2 Diabetes Promotes the Microglial Pyroptosis by Activating NLRP3 Inflammasome to Impede Remyelination After Spinal Cord Injury. [PDF]

Research (Wash D C)
Xu J, Fang L, Wei T, Cai S, Chen R, Wang B, Nie S, Wu Y, Yan F, Shao J, Wu W, Zhan Y, Xu K, Xiao J, Wu Y.   +14 more
europepmc   +1 more source

Remyelination therapies are achievable in clinical practice-No. [PDF]

Mult Scler
Shirani A, Stuve O.
europepmc   +1 more source

Angiotensin II impairs the remyelination mediated by brain endothelial cell-derived exosomes. [PDF]

Acta Neuropathol Commun
Yuan Y, Liang S, Guan A, Sun J, Shen W, Dong Q, Guo M, Cui M.   +7 more
europepmc   +1 more source

Editorial: Expanding the glial frontiers: development, function and pathophysiology. [PDF]

Front Cell Neurosci
Kim DW.
europepmc   +1 more source

Zuo Gui Wan Promotes Remyelination in Multiple Sclerosis by Attenuating MAPK-Mediated Microglial M1 Polarization, an Integrated Network Pharmacology and Experimental Validation Study. [PDF]

J Inflamm Res
Zhao P, Li Y, Li W, Han X, Cheng W, Fan M, Xu L, Han J, Liu X.   +8 more
europepmc   +1 more source